Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. [electronic resource]
Producer: 19940207Description: 337-45 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Blood Component Transfusion
- Bone Marrow Transplantation
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Granulocyte-Macrophage Colony-Stimulating Factor -- therapeutic use
- Hematopoietic Stem Cell Transplantation
- Hodgkin Disease -- drug therapy
- Humans
- Immunologic Factors -- therapeutic use
- Life Tables
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Prognosis
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.